<DOC>
	<DOC>NCT00849992</DOC>
	<brief_summary>Actinic cheilitis is a common precancerous lesion of the lip. The purpose of this study is to compare imiquimod 5% therapy and photodynamic therapy. The data will include effect data, histology (skin analysis), epidemiological data and follow-up data.</brief_summary>
	<brief_title>Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic Therapy</brief_title>
	<detailed_description>Randomized study comparing imiquimod 5% with photodynamic therapy for actinic cheilitis. Histological, efficacy, epidemiological and clinical data will be collected.</detailed_description>
	<mesh_term>Cheilitis</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Clinical findings of actinic cheilitis. Histological findings demonstrating epithelial changes equal to or greater than mild epithelial dysplasia in severity (mild moderate severe). Age above 18. Willingness to take posttreatment biopsy. Disorders predisposing to photosensitivity (porphyria, SLE). Pregnancy or nursing. Known allergy to any excipients in the study creams. prescribed topical retinoids, 5fluorouracil, cryodestruction, surgical excision and curettage.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Actinic cheilitis</keyword>
	<keyword>Imiquimod 5%</keyword>
	<keyword>Photodynamic therapy</keyword>
</DOC>